Elvitegravir

CAS No. 697761-98-1

Elvitegravir( GS-9137, JTK-303 )

Catalog No. M15676 CAS No. 697761-98-1

Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM in cell-free assays, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 45 In Stock
5MG 45 In Stock
10MG 75 In Stock
25MG 147 In Stock
50MG 277 In Stock
100MG 452 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Elvitegravir
  • Note
    Research use only, not for human use.
  • Brief Description
    Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM in cell-free assays, respectively.
  • Description
    Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM in cell-free assays, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GS-9137, JTK-303
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV-1 IIIB| HIV-2 EHO| HIV-2 ROD
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    697761-98-1
  • Formula Weight
    447.88
  • Molecular Formula
    C23H23ClFNO5
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 35 mg/mL (78.14 mM); DMSO: 90 mg/mL (200.94 mM)
  • SMILES
    CC(C)[C@@H](CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shimura K, et al. J Virol. 2008, 82(2), 764-774.
molnova catalog
related products
  • Cosalane

    Cosalane (NSC 658586) is an HIV replication inhibitor, an inhibitor of chemokine receptor 7 (CCR7) signalling in humans and mice, with antiviral activity that blocks the binding of CCR7 to its natural ligands, CCL19 and CCL21.

  • HIV p17 Gag 77-85

    HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.

  • Nelfinavir

    A potent and orally bioavailable HIV-1 protease inhibitor with Ki of 2 nM.